Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Decreased tacrolimus levels after administration of rifampin to a patient with renal transplant.

Literature DB >> 24357873

Decreased tacrolimus levels after administration of rifampin to a patient with renal transplant.

Heather Naylor¹, Jenna Robichaud².

Abstract

Entities: Chemical Species

Year: 2013 PMID： 24357873 PMCID： PMC3867568 DOI： 10.4212/cjhp.v66i6.1313

Source DB: PubMed Journal: Can J Hosp Pharm ISSN： 0008-4123

× No keyword cloud information.

21 in total

Review 1. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.

Authors: Christine E Staatz; Lucy K Goodman; Susan E Tett
Journal: Clin Pharmacokinet Date: 2010-03 Impact factor: 6.447

2. Influence of the CYP3A5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients.

Authors: Mariano Ferraresso; Amedea Tirelli; Luciana Ghio; Paolo Grillo; Valentina Martina; Erminio Torresani; Alberto Edefonti
Journal: Pediatr Transplant Date: 2007-05

3. Overcoming the effect of rifampin on the tacrolimus metabolism by itraconazole administration in an allogeneic hematopoietic stem cell transplant recipient.

Authors: Takehiko Mori; Yoshinobu Aisa; Jun Kato; Yukinori Nakamura; Takayuki Shimizu; Shinichiro Okamoto
Journal: Int J Hematol Date: 2010-03-02 Impact factor: 2.490

Review 4. Genetic contribution to variable human CYP3A-mediated metabolism.

Authors: Jatinder K Lamba; Yvonne S Lin; Erin G Schuetz; Kenneth E Thummel
Journal: Adv Drug Deliv Rev Date: 2002-11-18 Impact factor: 15.470

5. Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians.

Authors: Iain A M Macphee; Salim Fredericks; Maha Mohamed; Michelle Moreton; Nicholas D Carter; Atholl Johnston; Lawrence Goldberg; David W Holt
Journal: Transplantation Date: 2005-02-27 Impact factor: 4.939

6. Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients.

Authors: Miwa Uesugi; Satohiro Masuda; Toshiya Katsura; Fumitaka Oike; Yasutsugu Takada; Ken-ichi Inui
Journal: Pharmacogenet Genomics Date: 2006-02 Impact factor: 2.089

7. Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications.

Authors: M A Chisholm; L L Mulloy; M Jagadeesan; J T DiPiro
Journal: Clin Transplant Date: 2001-10 Impact factor: 2.863

Review 8. Regulation of cytochromes P450 during inflammation and infection.

Authors: E T Morgan
Journal: Drug Metab Rev Date: 1997-11 Impact factor: 4.518

Review 9. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors: Christine E Staatz; Susan E Tett
Journal: Clin Pharmacokinet Date: 2004 Impact factor: 6.447

10. Severe reduction in tacrolimus levels with rifampin despite multiple cytochrome P450 inhibitors: a case report.

Authors: S Bhaloo; G V R Prasad
Journal: Transplant Proc Date: 2003-11 Impact factor: 1.066

5 in total

Review 1. Pharmacologic Management of Mycobacterium chimaera Infections: A Primer for Clinicians.

Authors: Matt Mason; Eric Gregory; Keith Foster; Megan Klatt; Sara Zoubek; Albert J Eid
Journal: Open Forum Infect Dis Date: 2022-06-15 Impact factor: 4.423

2. Supratherapeutic Tacrolimus Concentrations With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients Requiring Hospitalization: A Case Series Using Rifampin for Reversal.

Authors: Dusten T Rose; Saurin M Gandhi; Rachael A Bedard; Kristin E Mondy; Alexander L Chu; Kelly C Gamble; Amanda T Gee; Monica A Kundra; Amber L Williams; Brian K Lee
Journal: Open Forum Infect Dis Date: 2022-05-13 Impact factor: 4.423